SCHEMBL25029029

SCHEMBL25029029

CN1CCC(Oc2cccc(-c3c[nH]c4c(C#N)cccc34)n2)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 P31645 2/20 0.48
▸ SLC6A2 P23975 1/20 0.48
▸ KCNH2 Q12809 1/20 0.48
▸ GSK3B P49841 2/20 0.48
▸ DYRK1A Q13627 2/20 0.48
▸ NFATC1 O95644 1/20 0.48
▸ NOS3 P29474 1/20 0.45
▸ NOS1 P29475 1/20 0.45
▸ NOS2 P35228 1/20 0.45
▸ PIM1 P11309 7/20 0.38
▸ PIM2 Q9P1W9 7/20 0.38
▸ PIM3 Q86V86 6/20 0.38
▸ CDK7 P50613 1/20 0.36
▸ CCNH P51946 1/20 0.36
▸ MNAT1 P51948 1/20 0.36
▸ PDE10A Q9Y233 1/20 0.36
▸ CCNT1 O60563 1/20 0.36
▸ CCNK O75909 1/20 0.36
▸ CCNE1 P24864 1/20 0.36
▸ CDK2 P24941 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29363716 1.00 SLC6A4 (0.48) SLC6A4SLC6A2KCNH2GSK3BDYRK1A
SCHEMBL26717234 0.85 NOS3 (0.48) SLC6A4GSK3BDYRK1ANFATC1NOS3
SCHEMBL29364398 0.83 SLC6A4 (0.49) SLC6A4SLC6A2KCNH2GSK3BDYRK1A
SCHEMBL25029229 0.83 SLC6A4 (0.49) SLC6A4SLC6A2KCNH2GSK3BDYRK1A
SCHEMBL29364026 0.83 DYRK1A (0.45) SLC6A4KCNH2GSK3BDYRK1ANFATC1
SCHEMBL25029046 0.83 DYRK1A (0.45) SLC6A4KCNH2GSK3BDYRK1ANFATC1
SCHEMBL26717749 0.75 NFATC1 (0.43) GSK3BDYRK1ANFATC1NOS3NOS1
SCHEMBL25029295 0.74 NFATC1 (0.43) GSK3BDYRK1ANFATC1NOS3NOS1
SCHEMBL29361860 0.74 NFATC1 (0.43) GSK3BDYRK1ANFATC1NOS3NOS1
SCHEMBL25029296 0.74 GSK3B (0.41) GSK3BDYRK1ANFATC1CDK7CCNH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348439-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES INC (US) 2023-11-02 — — US disclosed
US-20230348439-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES INC (US) 2023-11-02 — — US disclosed
US-11667624-B2 Indole compounds as androgen receptor modulators NIDO BIOSCIENCES, INC. (US) 2023-06-06 — — US disclosed
US-11667624-B2 Indole compounds as androgen receptor modulators NIDO BIOSCIENCES, INC. (US) 2023-06-06 — — US disclosed
EP-4182320-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS Nido Biosciences, Inc. (US) 2023-05-24 — — EP disclosed
CN-115996926-A Indole compounds as androgen receptor modulators 尼多生物科学有限公司 2023-04-21 — — CN disclosed
US-20230049406-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES, INC. 2023-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230049406-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS AR, FSHR, NR5A1 SLC6A4 234/4885SLC6A2 609/4885KCNH2 3984/4885
US-20230348439-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS AR, FSHR, NR5A1 SLC6A4 236/4885SLC6A2 629/4885KCNH2 3930/4885
US-11667624-B2 Indole compounds as androgen receptor modulators AR, FSHR, ADRB3 SLC6A4 194/4885SLC6A2 450/4885KCNH2 3567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback